Viewing Study NCT02267967


Ignite Creation Date: 2025-12-25 @ 12:43 AM
Ignite Modification Date: 2026-01-05 @ 2:36 AM
Study NCT ID: NCT02267967
Status: COMPLETED
Last Update Posted: 2018-11-13
First Post: 2014-10-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase Ib/II Study of Sulfatinib in Treating Advanced Neuroendocrine Tumors
Sponsor: Hutchison Medipharma Limited
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module